Du G G, MacLennan D H
Banting and Best Department of Medical Research, University of Toronto, Toronto, Ontario M5G 1L6, Canada.
J Biol Chem. 1999 Sep 10;274(37):26120-6. doi: 10.1074/jbc.274.37.26120.
Ca(2+) activation of skeletal (RyR1) and cardiac (RyR2) muscle Ca(2+) release channels (ryanodine receptors) occurs with EC(50) values of about 1 microM. Ca(2+) inactivation occurs with an IC(50) value of about 3.7 mM for RyR1, but RyR2 shows little inactivation, even at >100 mM Ca(2+). In an attempt to localize the low affinity Ca(2+) binding sites responsible for Ca(2+) inactivation in RyR1, chimeric RyR1/RyR2 molecules were constructed. Because [(3)H]ryanodine binds only to open channels, and because channel opening and closing are Ca(2+)-dependent, the Ca(2+) dependence of [(3)H]ryanodine binding was used as an indirect measurement of Ca(2+) release channel opening and closing. IC(50) values for [(3)H]ryanodine binding suggested that Ca(2+) affinity for the low affinity Ca(2+) inactivation sites was unchanged in a chimera in which a glutamate-rich sequence (amino acids 1743-1964) in RyR1 was replaced with the corresponding, less acidic sequence from RyR2. Ca(2+) affinity (IC(50)) for low affinity Ca(2+) inactivation sites was intermediate in RyR1/RyR2 chimeras containing RyR2 amino acids 3726-4186 (RF9), 4187-4628 (RF10), or 4629-5037 (RF11), was closer to RyR2 values in RyR1 chimeras with longer RyR2 replacements (RF9/10 or RF10/11), and was indistinguishable from RyR2 in RyR1 containing all three RyR2 replacements (RF9/10/11). These data suggest that multiple low affinity Ca(2+) binding sites or multiple components of a low affinity Ca(2+) binding site are located between amino acids 3726 and 5037 and that their effects on Ca(2+) inactivation of the release channel are cooperative. Measurement of Ca(2+) activation of [(3)H]ryanodine binding showed that chimeras RF10, RF9/10, and RF9/10/11 were more sensitive to Ca(2+) than was either RyR1 or RyR2. Measurement of caffeine activation of Ca(2+) release in vivo showed that chimeras RF9, RF10, RF9/10, RF10/11, and RF9/10/11 were more sensitive to caffeine than wild-type RyR1. These results suggest that Ca(2+) and caffeine activation sites also involve COOH-terminal sequences in RyR1 and RyR2.
骨骼肌(RyR1)和心肌(RyR2)的钙释放通道(雷诺丁受体)的Ca(2+)激活发生时,其半数有效浓度(EC(50))值约为1微摩尔。对于RyR1,Ca(2+)失活发生时的半数抑制浓度(IC(50))值约为3.7毫摩尔,但即使在Ca(2+)浓度>100毫摩尔时,RyR2也几乎没有失活。为了定位负责RyR1中Ca(2+)失活的低亲和力Ca(2+)结合位点,构建了嵌合的RyR1/RyR2分子。由于[(3)H]雷诺丁仅与开放通道结合,且通道的开放和关闭依赖于Ca(2+),因此[(3)H]雷诺丁结合的Ca(2+)依赖性被用作Ca(2+)释放通道开放和关闭的间接测量指标。[(3)H]雷诺丁结合的IC(50)值表明,在一个嵌合体中,RyR1中富含谷氨酸的序列(氨基酸1743 - 1964)被RyR2中相应的酸性较弱的序列所取代,此时Ca(2+)对低亲和力Ca(2+)失活位点的亲和力未发生改变。对于包含RyR2氨基酸3726 - 4186(RF9)、4187 - 4628(RF10)或4629 - 5037(RF11)的RyR1/RyR2嵌合体,低亲和力Ca(2+)失活位点的Ca(2+)亲和力(IC(50))处于中间水平;在具有更长RyR2替换序列的RyR1嵌合体(RF9/10或RF10/11)中,其更接近RyR2的值;而在包含所有三个RyR2替换序列的RyR1(RF9/10/11)中,其与RyR2的值难以区分。这些数据表明,多个低亲和力Ca(2+)结合位点或低亲和力Ca(2+)结合位点的多个组成部分位于氨基酸3726和5037之间,并且它们对释放通道Ca(2+)失活的影响是协同的。[(3)H]雷诺丁结合的Ca(2+)激活测量表明,嵌合体RF10、RF9/10和RF9/10/11比RyR1或RyR2对Ca(2+)更敏感。体内Ca(2+)释放的咖啡因激活测量表明,嵌合体RF9、RF10、RF9/10、RF10/11和RF9/10/11比野生型RyR1对咖啡因更敏感。这些结果表明,Ca(2+)和咖啡因激活位点也涉及RyR1和RyR2中的COOH末端序列。